Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Kabra Drugs Ltd has informed BSE that the trading window for dealing in its securities will be closed for all designated persons and their immediate relatives from 1st April 2026. The window will remain shut until 48 hours after the company declares its unaudited financial results for the quarter ended 31st March 2026 (Q4 FY26). The exact date of the board meeting to consider these results will be communicated later. This is a routine compliance measure under SEBI's Insider Trading Regulations, 2015.
This is a standard regulatory filing and carries no direct impact on shareholders or stock price. It simply means company insiders cannot trade in the stock during the pre-results blackout period, which is normal practice ahead of earnings announcement.